For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Covid-19: 2414 new cases, 22 further deaths
FREE READ
+News
FREE READ
Covid-19: 2414 new cases, 22 further deaths
Monday 22 July 2024, 04:46 PM

[Image: CDC on Unsplash]
There have been 2414 new cases of Covid-19 reported in New Zealand over the week to Sunday, and 22 further deaths attributed to the virus.
Of the new cases, 1429 were reinfections.
There were 162 cases in hospital, none of whom were in intensive care.
The greatest number of new cases reported over the past week were in Canterbury, followed by Waitematā and Counties Manukau.
Last week, Te Whatu Ora reported 2640 new cases of Covid-19 over the week, and 30 further deaths attributed to the virus.
For more news from around New Zealand, go to RNZ.